Articles published by VBI Vaccines Inc.
![](https://mms.businesswire.com/media/20240802116901/en/2205203/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Provides an Update on its Restructuring Proceedings
August 02, 2024
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20240730295745/en/2199856/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240625000048/en/2169809/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Announces Results of Annual General Meeting
June 25, 2024
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20240529424108/en/2143478/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240522640304/en/2137905/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240515040100/en/2132365/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240416638037/en/2098599/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Reports Full Year 2023 Financial Results
April 16, 2024
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20240411131707/en/2096064/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240409137528/en/2093687/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
April 09, 2024
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20240403068954/en/2087279/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240402068244/en/2085426/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20240214531599/en/2033794/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20231120733718/en/1948947/22/VBI_Vaccines_Primary.jpg)
![](https://mms.businesswire.com/media/20231114900702/en/1945254/22/VBI_Vaccines_Primary.jpg)
VBI Vaccines Reports Third Quarter 2023 Financial Results
November 14, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20231026897720/en/1925934/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230927612394/en/1900214/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230907734558/en/1883559/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBM
September 07, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20230906245918/en/1882791/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230814872763/en/1865702/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Reports Second Quarter 2023 Financial Results
August 14, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20230724431781/en/1847452/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230719628465/en/1844491/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230706131987/en/1835190/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230629024275/en/1832258/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230629353376/en/1832182/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230623028843/en/1827189/22/VBI_Vaccines_Primary.jpg)
VBI Vaccines Announces Results of Annual General Meeting
June 23, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20230615368901/en/1819797/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230607005195/en/1812535/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Announces Poster Presentation at EASL 2023
June 07, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20230515005242/en/1792961/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
![](https://mms.businesswire.com/media/20230425005302/en/1772810/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Appoints Vaughn Himes to Board of Directors
April 25, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
![](https://mms.businesswire.com/media/20230404005433/en/1755205/22/VBI_Vaccines_Logo_Horiz_RGB.jpg)
VBI Vaccines Announces Increased Focus on Hepatitis B, Organizational Changes, and Reverse Stock Split
April 04, 2023
From VBI Vaccines Inc.
Via Business Wire
Tickers
VBIV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.